| 1 |
33119931 | A UPLC-MS/MS method for determination of endogenous l-carnitine and acetyl-l-carnitine in serum of patients with depression. | 2021 Mar |
1 |
| 2 |
34056884 | Efficacy of a fixed combination of palmitoylethanolamide and acetyl-l-carnitine (PEA+ALC FC) in the treatment of neuropathies secondary to rheumatic diseases. | 2021 Aug |
1 |
| 3 |
34658942 | L-Carnitine and Acetyl-L-Carnitine: Potential Novel Biomarkers for Major Depressive Disorder. | 2021 |
1 |
| 4 |
31019265 | iPSC-derived homogeneous populations of developing schizophrenia cortical interneurons have compromised mitochondrial function. | 2020 Nov |
1 |
| 5 |
32408706 | Acetyl-L-Carnitine in Dementia and Other Cognitive Disorders: A Critical Update. | 2020 May 12 |
1 |
| 6 |
28534301 | Effects of acetyl-L-carnitine in diabetic neuropathy and other geriatric disorders. | 2018 Feb |
1 |
| 7 |
24607292 | A review of current evidence for acetyl-l-carnitine in the treatment of depression. | 2014 Jun |
1 |
| 8 |
22027664 | [Acetyl-L-carnitine (carnicetine) in the treatment of early stages of Alzheimer's disease and vascular dementia]. | 2011 |
1 |
| 9 |
15138763 | Acetyl-L-carnitine reduces impulsive behaviour in adolescent rats. | 2004 Nov |
1 |
| 10 |
12804452 | Acetyl-L-carnitine for dementia. | 2003 |
1 |
| 11 |
12841930 | Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. | 2003 |
1 |